Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer

We love to hear from our listeners. Send us a message. Episode 115 of Cell & Gene: The Podcast features Host Erin Harris' talk with Aliya Omer, Vice President and Global Head of Hematology and Cell Therapy at AstraZeneca. Omer shares valuable insights from her rich experience leading cell therapy development across multiple top companies. She highlights the critical importance of collaboration by breaking down silos across research, manufacturing, regulatory, and commercial teams to deliver innovative therapies efficiently. She also discusses AZ’s diverse and ambitious cell therapy portfolio, encompassing autologous CAR-T, TCR-T, in vivo gene therapies, and regulatory T-cell therapies. She candidly addresses current challenges in manufacturing scalability, patient access, and healthcare system readiness and describes how AZ is prioritizing fast manufacturing platforms and ecosystem-wide partnerships to surmount these hurdles.

You can listen to Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer online on Radio and Podcast. Open the player on this page to stream the available audio.

Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer is an episode from Cell & Gene: The Podcast by Erin Harris.

This episode is 34:02 long.

This episode was published on Nov 6, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Cell & Gene: The Podcast when more episodes are available from the podcast feed.